» Articles » PMID: 15133506

Reversal of Obesity by Targeted Ablation of Adipose Tissue

Overview
Journal Nat Med
Date 2004 May 11
PMID 15133506
Citations 219
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is an increasingly prevalent human condition in developed societies. Despite major progress in the understanding of the molecular mechanisms leading to obesity, no safe and effective treatment has yet been found. Here, we report an antiobesity therapy based on targeted induction of apoptosis in the vasculature of adipose tissue. We used in vivo phage display to isolate a peptide motif (sequence CKGGRAKDC) that homes to white fat vasculature. We show that the CKGGRAKDC peptide associates with prohibitin, a multifunctional membrane protein, and establish prohibitin as a vascular marker of adipose tissue. Targeting a proapoptotic peptide to prohibitin in the adipose vasculature caused ablation of white fat. Resorption of established white adipose tissue and normalization of metabolism resulted in rapid obesity reversal without detectable adverse effects. Because prohibitin is also expressed in blood vessels of human white fat, this work may lead to the development of targeted drugs for treatment of obese patients.

Citing Articles

Microneedle-Mediated Treatment of Obesity.

Pan H, Hu W, Zhou C, Jian J, Xu J, Lu C Pharmaceutics. 2025; 17(2).

PMID: 40006614 PMC: 11859603. DOI: 10.3390/pharmaceutics17020248.


Vascular-Adipose Crosstalk: Angiogenesis and Adipose Tissue Remodeling.

Fitzgibbons T, Kogan S, Tran K Circ Res. 2025; 136(1):112-114.

PMID: 39745990 PMC: 11698489. DOI: 10.1161/CIRCRESAHA.124.325899.


Two-Pronged Attack: Dual Activation of Fat Reduction Using Near-Infrared-Responsive Nanosandwich for Targeted Anti-Obesity Treatment.

Xiao Q, Tang L, Chen S, Mei Y, Wang C, Yang J Adv Sci (Weinh). 2024; 11(43):e2406985.

PMID: 39324577 PMC: 11578330. DOI: 10.1002/advs.202406985.


Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery.

Engin A, Engin E, Engin A Adv Exp Med Biol. 2024; 1460:657-676.

PMID: 39287868 DOI: 10.1007/978-3-031-63657-8_22.


Loss of prohibitin 2 in Schwann cells dysregulates key transcription factors controlling developmental myelination.

Wilson E, Della-Flora Nunes G, Shen S, Moore S, Gawron J, Maxwell J Glia. 2024; 72(12):2247-2267.

PMID: 39215540 PMC: 11577967. DOI: 10.1002/glia.24610.